ZA965234B - Bioavailable crystalline form of cefuroxime exetil - Google Patents

Bioavailable crystalline form of cefuroxime exetil

Info

Publication number
ZA965234B
ZA965234B ZA965234A ZA965234A ZA965234B ZA 965234 B ZA965234 B ZA 965234B ZA 965234 A ZA965234 A ZA 965234A ZA 965234 A ZA965234 A ZA 965234A ZA 965234 B ZA965234 B ZA 965234B
Authority
ZA
South Africa
Prior art keywords
exetil
cefuroxime
crystalline form
bioavailable
bioavailable crystalline
Prior art date
Application number
ZA965234A
Other languages
English (en)
Inventor
Maurizio Zenoni
Mario Leone
Angelo Cattaneo
Leonardo Marsili
Original Assignee
Acs Dobfar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acs Dobfar Spa filed Critical Acs Dobfar Spa
Publication of ZA965234B publication Critical patent/ZA965234B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA965234A 1995-08-03 1996-06-20 Bioavailable crystalline form of cefuroxime exetil ZA965234B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001716A IT1277426B1 (it) 1995-08-03 1995-08-03 Forma cristallina biodisponibile del cefuroxima axetil

Publications (1)

Publication Number Publication Date
ZA965234B true ZA965234B (en) 1997-03-06

Family

ID=11372130

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965234A ZA965234B (en) 1995-08-03 1996-06-20 Bioavailable crystalline form of cefuroxime exetil

Country Status (24)

Country Link
US (1) US5677443A (ja)
EP (1) EP0757991B1 (ja)
JP (1) JPH09104685A (ja)
KR (1) KR970010776A (ja)
CN (1) CN1055693C (ja)
AR (1) AR003973A1 (ja)
AT (1) ATE195126T1 (ja)
BR (1) BR9603270A (ja)
CA (1) CA2179359A1 (ja)
DE (1) DE69609576T2 (ja)
DK (1) DK0757991T3 (ja)
ES (1) ES2150052T3 (ja)
FI (1) FI962937A (ja)
GR (1) GR3034663T3 (ja)
IL (1) IL118822A (ja)
IT (1) IT1277426B1 (ja)
MX (1) MX9603110A (ja)
PT (1) PT757991E (ja)
RU (1) RU2155767C2 (ja)
SI (1) SI0757991T1 (ja)
TR (1) TR199600691A2 (ja)
TW (1) TW413635B (ja)
UA (1) UA46727C2 (ja)
ZA (1) ZA965234B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725382B1 (fr) * 1994-10-05 1997-01-03 Commissariat Energie Atomique Polyazacycloalcanes, complexes tri-, tetra- ou pentaazamacrocycliques, procede de fabrication de ces polyazacycloalcanes substitues ou non et greffes sur un support et utilisations des polyazacycloalcanes
NZ299077A (en) * 1996-07-26 1998-06-26 Apotex Inc Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
KR100401284B1 (ko) * 1997-06-03 2004-01-31 주식회사유한양행 1-브로모에틸 아세테이트의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (ja) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ES2171056T3 (es) * 1998-02-20 2002-08-16 Fako Ilaclari A S Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble.
US6384213B1 (en) 1998-10-23 2002-05-07 Ranbaxy Laboratories Limited Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
IN190849B (ja) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
HRP20020924A2 (en) * 2001-11-23 2003-10-31 Glaxo Group Ltd Pharmaceutical composition
CN1909889B (zh) * 2004-01-09 2010-06-02 韩美药品株式会社 头孢呋辛酯颗粒及其制备方法
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
WO2007063552A1 (en) * 2005-12-02 2007-06-07 Lupin Limited Stable taste masked formulations of cephalosporins
DE102006019619A1 (de) * 2006-04-25 2007-10-31 Grünenthal GmbH Kristalline Modifikation von Cefuroximaxetil
CN102417451B (zh) * 2011-12-20 2013-12-04 浙江国邦药业有限公司 一种合成（r，s）1-溴代乙基乙酸酯的制备方法
CN103717607A (zh) * 2012-09-12 2014-04-09 海南卫康制药(潜山)有限公司 头孢呋辛钠新晶型化合物及其组合物粉针
CN106554361B (zh) * 2016-09-30 2018-10-09 华北制药河北华民药业有限责任公司 一种头孢呋辛酯口服制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Also Published As

Publication number Publication date
SI0757991T1 (en) 2000-12-31
FI962937A0 (fi) 1996-07-23
TW413635B (en) 2000-12-01
IT1277426B1 (it) 1997-11-10
EP0757991A1 (en) 1997-02-12
DE69609576D1 (de) 2000-09-07
DE69609576T2 (de) 2001-01-04
FI962937A (fi) 1997-02-04
JPH09104685A (ja) 1997-04-22
PT757991E (pt) 2000-11-30
CA2179359A1 (en) 1997-02-04
KR970010776A (ko) 1997-03-27
CN1055693C (zh) 2000-08-23
AU700214B2 (en) 1998-12-24
IL118822A (en) 1999-11-30
ITMI951716A0 (it) 1995-08-03
IL118822A0 (en) 1996-10-31
DK0757991T3 (da) 2000-09-04
UA46727C2 (uk) 2002-06-17
RU2155767C2 (ru) 2000-09-10
AU6083396A (en) 1997-02-06
ATE195126T1 (de) 2000-08-15
TR199600691A3 (tr) 1998-03-21
US5677443A (en) 1997-10-14
AR003973A1 (es) 1998-09-30
CN1147516A (zh) 1997-04-16
ES2150052T3 (es) 2000-11-16
BR9603270A (pt) 1998-04-28
ITMI951716A1 (it) 1997-02-03
MX9603110A (es) 1997-06-28
GR3034663T3 (en) 2001-01-31
EP0757991B1 (en) 2000-08-02
TR199600691A2 (xx) 1998-03-21

Similar Documents

Publication Publication Date Title
ZA965234B (en) Bioavailable crystalline form of cefuroxime exetil
HK1023125A1 (en) Crystalline form of 4-Ä5-methyl-3-phenylisoxazol-4-ylÜbenzenesulfonamide
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
AU2588292A (en) Aminodiesters of rapamycin
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
AU5426096A (en) Uses of antibacterial compounds
PL306127A1 (en) Derivatives of epi-epibathydine
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
HU9602433D0 (en) Cephalosporin derivatives
EP0750058A3 (en) Doping of crystal substrates
PL337612A1 (en) Crystalline form of roxyfiban
ZA95694B (en) Novel derivatives of tetramethylcyclopropane
AU700214C (en) Bioavailable crystalline form of cefuroxime axetil
PL325602A1 (en) Alternative crystalline form of thazophenelone
GB9504913D0 (en) Production of trialkoxypropane
HRP930890B1 (en) The production of crystalline l-sorbose
TW301373U (en) Improved structure of screw
ZA966266B (en) Cephalosporin fluoroquinolonate derivatives
ZA965026B (en) Doping of crystalline substrates
KR0110698Y1 (en) Suspension of autoseat
GB9216483D0 (en) Novel crystalline intermediate
IL108238A0 (en) Deposition of amorphous silicon
GB9316089D0 (en) Novel crystalline intermediate
TW340437U (en) Engagement of an improved wrench